Treatment with infliximab may contribute to the development of peripheral neuropathy among the patients with rheumatoid arthritis

Clin Rheumatol. 2007 Sep;26(9):1595-6. doi: 10.1007/s10067-007-0657-3. Epub 2007 Jun 5.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal / therapeutic use
  • Arthritis, Rheumatoid / drug therapy
  • Electromyography
  • Female
  • Humans
  • Infliximab
  • Male
  • Peripheral Nervous System Diseases / chemically induced*
  • Prospective Studies
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Antibodies, Monoclonal
  • Tumor Necrosis Factor-alpha
  • Infliximab